BioSante Pharmaceuticals, Inc. (BPAX)

[Just the facts maam]

Professor, since the efficacy trials determined that there was basically no statistical difference between placebo and Libigel (both showed marked improvement). It would be interesting to see the FDA response to an application for HSSD approval with the efficacy being proven equal to placebo and requesting approval on the basis that placebo was significantly less safe then Libigel.

I realize this is not the norm, but you have to admit a strong argument could be made.